What’s happening to generic drug prices? February 2020 NADAC Survey Update

It’s NADAC survey results week, which means it’s time for our next installment of “what happened to generic drug prices last month.” We saw more price increases than decreases this past month, and for the first time in eight months, an increase in annualized spending based on typical utilization trends. As always, the details matter, and we’re here to provide them for you. Check out our latest drug pricing report for important updates on the latest generic drug price changes, plus an updated NADAC Packed Bubble Chart.

Ben LinkMarch 9, 2020NADAC, Medicaid, Generic, Buprenorphine-Naloxone, Gleevec, Imatinib, Zantac, Ranitidine, Zomig, Zolmitriptan, GoodRx, AWP, Drug List Price, ICER